FDA: Diabetes Drug Invokana May Raise Risk Of Osteoporosis

The U.S. Food and Drug Administration (FDA) has revised the label for Invokana based on findings that patients who take the diabetes drug may have an increased risk of suffering bone fracture. Clinical trials show that the Invokana may raise the risk of bone mineral density loss, which can lead to osteoporosis. The FDA has revised the drug’s warning labels to reflect both of these serious risks, Arkansas Invokana lawyers note.

If you or a loved one suffered complications after taking Invokana, contact Attorney Group for Arkansas today to discuss your options in a free, confidential, no-obligation consultation. We can answer your questions, and if you decide to pursue a claim for compensation, we can connect you with an affiliated Invokana lawsuit attorney who can assist you throughout the legal process.

The time you have to pursue a claim is limited. Contact us for more information.Get Help Now.

FDA Updates Invokana’s Warning labels

According to an FDA Drug Safety Communication, a clinical trial suggests that Invokana, which is a drug prescribed to help diabetic individuals manage their blood sugar, is associated with a greater risk of bone mineral density loss and fractures. According to the FDA, previous research had already established a connection between Invokana and bone fractures. However, the strength of the recent findings, along with new information about the risk of osteoporosis associated with Invokana, caused the FDA to update the drug’s warning labels.

Many of the clinical trials compared outcomes in patients who used Invokana and those who took placebos. One trial found that Invokana caused more depletion of hip and lower spine bone mineral density than a placebo. Another trial found that patients were vulnerable to bone fractures as soon as 12 weeks after they began taking Invokana. Many of the fractures observed during the trials occurred after fairly minor traumatic incidents, such as falls from a standing position, the agency reported.

Injured Patients May Be Entitled to Compensation

Drug manufacturers have a duty to ensure their products are accompanied by full and accurate instructions and warnings to guide prescribing doctors and other health care providers in making treatment decisions. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.

Patients who have been injured by Invokana may be entitled to compensation for damages, including:

  • Medical expenses
  • Pain, suffering, and mental anguish
  • Loss of income or ability to work

If a patient dies from complications after taking Invokana, his or her family members may be able to pursue claims for their loved one’s wrongful death. Compensation may include:

  • Pain, suffering, and mental anguish from the loss of a loved one
  • Loss of financial support of a loved one
  • Funeral expenses

Affected patients are encouraged to speak with an Arkansas Invokana attorney to learn more about their rights and remedies.

Contact Us For More Information

If you or a loved one took Invokana and suffered complications, contact Attorney Group for Arkansas for more information. You can fill out the form on this page, call us at the number listed at the top of the page, or email us at info@attorneygroup.com.

When you contact us, an attorney will follow up with you to speak with you about your case or answer questions that you might have. There is no cost or obligation to speak with us, and any information you provide will be kept confidential.

Please note that the law limits the time you have to pursue a claim for an injury. If you think you have a case, you should not delay taking action.

See our Frequently Asked Questions page for more information, and contact Attorney Group for Arkansas today

Comments